You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Sphingosine Kinase Inhibitors of Diabetic Retinopathy

    SBC: Apogee Biotechnology Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term goal of this program is to identify and develop novel inhibitors of human sphingosine kinase (SK) that are effective as therapeutic agents. Because of its critical role in sphingolipid metabolism and angiogenesis, we have focused on SK as an innovative molecular target for the development of new drugs for the treatment of diabetic retinopathy. Sph ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  2. Sphingosine Kinase Inhibitors as Anti-IBD Agents

    SBC: Apogee Biotechnology Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term goal of this program is to develop novel inhibitors of human sphingosine kinase (SK) that are effective as therapeutic agents. Because of its critical role in sphingolipid metabolism, we have focused on SK as an innovative molecular target for the development of new drugs for the treatment of Inflammatory Bowel Diseases (IBDs). Sphingolipids are b ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  3. Sphingosine Kinase Inhibitors as Anti-Arthritis Agents

    SBC: Apogee Biotechnology Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term goal of this program is to develop novel inhibitors of human sphingosine kinase (SK) that are effective for the treatment of arthritis. Sphingolipids are being increasingly recognized as key mediators of apoptosis, stress responses, cell differentiation and proliferation, and are known to regulate the inflammatory cascade of central importance in ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Navigation Assistant for a Wheeled Walker

    SBC: AT SCIENCES, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): To address wayfinding difficulties and physical activity among cognitively-impaired older adults, we propose to develop a navigation aid that can be attached to three- and four-wheeled rollators. The navigation aid will provide navigation assistance to the user and will track the user's movements for later analysis by caregivers. Navigation assistance will be p ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Low-cost portable shareable wheelchair mobility

    SBC: AUGMENTECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Users of standard manual wheelchairs sometimes lack the endurance for extended travel or may be temporarily fatigued enough to need assistance with wheeled mobility. Elderly manual wheelchair users in nursing homes and assisted living facilities find their independence restricted by their lack of ability or their self-confidence to embark on extended travel wit ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  6. AV1: F-18 Radiopharmaceutical for Imaging Amyloid Plaque

    SBC: AVID RADIOPHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Alzheimer's disease (AD). The project is driven by the hypothesis that in vivo detection of amyloid plaques by positron emission computed tomography imaging (using radiolabeled amyloid binding probes) would allow for the early and definitive diagnosis of AD. A nove ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Radiopharmaceuticals for Imaging Brain Synuclein

    SBC: AVID RADIOPHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Dementia with Lewy Bodies (DLB). DLB is the second most common cause of dementia in the United States; although the disease requires specific pharmacologic management, current diagnostic methods are extremely inaccurate. DLB is often misdiagnosed as Alzheimer's dise ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Computer Assisted Surgery Prenatal Cardiac Intervention

    SBC: BLUE BELT TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): There is growing recognition that surgical repair of the heart is most likely to be successful in infancy (when there is dramatic capacity for growth and remodeling). For a subset of patients, the optimal time for intervention is prior to birth. Current prenatal cardiac intervention (PCI) procedures clearly have technical limitations in both fetal visualizat ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a Pediatric pVAD

    SBC: Cardiacassist, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Remarkable progress has been made over the last decade on ventricular assist devices for adult heart failure patients. Thousands of patients' lives have been saved each year. Unfortunately, similar devices are not yet available in the US for pediatric heart patients. Development of such devices has been impeded by the fact that the pediatric market size is t ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Crystal Transducers for Harmonic Imaging

    SBC: TRS CERAMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Contrast agent harmonic imaging has become a very important tool for studying blood perfusion. Due to the extensive amount of angiogenesis that occurs around malignant tumors, the use of ultrasound contrast agents has the potential to improve cancer diagnosis and to direct therapies. However, existing transducers are limited in their ability to form images from ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government